(Q40423962)

20 September 2017

1 reference

title

Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences (English)

1 reference

20 September 2017

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences (English)

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

19 May 2024

0 references

R. L. Capizzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577096

19 May 2024

W. Oster

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577096

19 May 2024

language of work or name

1 reference

1 January 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0959804995001448?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

https://api.elsevier.com/content/article/PII:0959804995001448?httpAccept=text/plain

19 May 2024

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

European Journal of Cancer

19 May 2024

published in

1 reference

20 September 2017

volume

31A Suppl 1

1 reference

20 September 2017

page(s)

S8-13

1 reference

WR-2721 protects against the hematologic toxicity of cyclophosphamide: a controlled phase II trial

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

19 May 2024

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

19 May 2024

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Use of radiation with or without WR-2721 in advanced rectal cancer

19 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.

19 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma

19 May 2024

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice

19 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)

19 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study

19 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(95)00144-8

19 May 2024

Identifiers

1 reference

20 September 2017

1 reference